Validated Micro-Dose Blending
Each tablet delivers Clonazepam 0.25 mg and Propranolol 10 mg with precision content uniformity and consistent dissolution kinetics complying with Indian Pharmacopoeia standards.
DELOTRIL-PRO-LS is a precision low-strength oral tablet combining Clonazepam IP 0.25 mg with Propranolol Hydrochloride IP 10 mg by Blessme, the dedicated neuro-psychiatric division of Dellwich Lifescience LLP. Specifically formulated to break the psycho-somatic anxiety loop by arresting central fear signaling in the amygdala while eliminating peripheral cardiac palpitations, tremors, and diaphoresis without heavy daytime sedation.

Detailed pharmaceutical specifications, active API monograph compliance, low-strength somatic synergy, and blister packaging details for DELOTRIL-PRO-LS.
DELOTRIL-PRO-LS unites micro-dose Clonazepam (0.25 mg) with low-dose Propranolol (10 mg) to offer an ideal first-line option for patients suffering from somatic anxiety manifestations, public speaking phobias, stage fright, and mild-to-moderate panic attacks.
In-depth pharmacological evaluation of Clonazepam IP 0.25 mg + Propranolol HCl IP 10 mg tablets, marketed as DELOTRIL-PRO-LS by Blessme (Dellwich Lifescience LLP). Covers neuro-autonomic mechanisms, performance anxiety protocols, and B2B pharmaceutical supply across India.
DELOTRIL-PRO-LS is a fixed-dose oral neuropsychiatric tablet engineered to manage anxiety conditions where physical symptoms dominate. Cognitive fear surges trigger sympathetic outflow from the hypothalamus, producing adrenaline rushes that accelerate heart rate, cause tremors, and stimulate sweating.
When doctors and distributors look for Clonazepam Propranolol tablet or low strength somatic anxiety medicine, they require precise dose balancing that calms both mind and body without inducing day-time lethargy. DELOTRIL-PRO-LS achieves this through automated clean-room compression under WHO-GMP compliance.
Evidence-based neuropsychiatric indications for DELOTRIL-PRO-LS include:
Clonazepam acts as a positive allosteric modulator on the GABAA receptor complex in the limbic cortex and amygdala, enhancing chloride ion conductance and dampening fear circuitry firing. At the 0.25 mg micro-dose, it delivers clean psychological calming without mental sluggishness.
Simultaneously, Propranolol competitively blocks peripheral beta-1 adrenergic receptors in the myocardium and beta-2 receptors in peripheral vascular and muscular tissues. This prevents adrenaline from inducing palpitations, tachycardia, and tremors. By eliminating physical alarm cues, the brain is not triggered into further panic, interrupting the vicious feedback loop.
Clinical criteria for selecting between the two strengths:
DELOTRIL-PRO-LS must be taken strictly in accordance with medical advice:
DELOTRIL-PRO-LS contains Clonazepam, which has potential for dependence and habit formation with prolonged use. Propranolol is contraindicated in bronchial asthma, severe bradycardia, and high-degree heart block. Dispensed strictly against a valid medical prescription.
DELOTRIL-PRO-LS is manufactured in WHO-GMP certified facilities adhering to Schedule M protocols, ensuring micro-blend homogeneity and maximum packaging stability.
Each tablet delivers Clonazepam 0.25 mg and Propranolol 10 mg with precision content uniformity and consistent dissolution kinetics complying with Indian Pharmacopoeia standards.
Sealed in tropicalized blister strips engineered to resist humidity, light exposure, and ambient temperature swings, preserving active potency across all Indian climate zones.
Every batch is backed by authenticated Certificates of Analysis (COA), disintegration profiles, assay validation data, and Material Safety Data Sheets for hospital audits.
Produced in state-of-the-art accredited manufacturing units in Gujarat adhering to automated compression, online check-weighing, and Good Laboratory Practices (GLP).
Prescribing guidance, contraindications, and drug interactions for Clonazepam + Propranolol tablets.
DELOTRIL-PRO-LS is a Schedule H prescription drug. Not for OTC sale. Do not consume alcohol during therapy. Exercise caution when driving or operating machinery.
Approved neurological and psychiatric indications for DELOTRIL-PRO-LS:
Key contraindications and monitoring requirements:
Dellwich Lifescience LLP is an established pharmaceutical company based in Science City, Ahmedabad, Gujarat, dedicated to advanced formulation technology, uncompromising quality assurance, and ethical healthcare supply. Through our specialized neurology division, Blessme, we manufacture and market superior neuro-psychiatric treatments, including DELOTRIL-PRO-LS (Clonazepam 0.25 mg + Propranolol 10 mg Tablets).
We support PCD pharma franchise partners, hospital supply chains, and contract manufacturing clients across India with guaranteed supply security, validated product dossiers, and prompt dispatch.
Whether you are seeking DELOTRIL-PRO-LS for district monopoly PCD franchise distribution, third-party contract manufacturing, or hospital bulk procurement, Dellwich Lifescience LLP delivers dependable supply and competitive trade margins.
Secure district-level monopoly marketing rights for DELOTRIL-PRO-LS and the Blessme neuropsychiatry range with visual aids, product glossaries, and promotional input support.
Turnkey manufacturing solutions for pharmaceutical marketing companies with flexible batch runs, rapid production turnaround, and full regulatory dossier support from Ahmedabad.
Direct bulk pharmaceutical supply agreements for multispecialty hospital chains, psychiatric nursing homes, and institutional medical tenders with prompt pan-India logistics.
When sourcing Clonazepam Propranolol tablets in India, DELOTRIL-PRO-LS by Blessme provides exceptional clinical efficacy, reliable blister packaging, and comprehensive B2B franchise support.
Manufactured in accredited facilities using IP grade APIs, ensuring exact active content uniformity and fast disintegration.
Tamper-evident, moisture-resistant blister strips protect tablets from ambient humidity and transport friction.
Direct factory dispatch with GST invoicing, verified batch COA, and dependable logistics coverage across all Indian states.
Exclusive district-level franchise rights for DELOTRIL-PRO-LS and the Blessme portfolio with promotional visual aids.
Certificates of Analysis (COA), stability testing data, and MSDS readily available for institutional audits and tenders.
Direct access to Dellwich Lifescience product specialists for quick quotes, customized bulk orders, and customer assistance.
Authoritative answers to clinical, commercial, dosage, and regulatory questions regarding Clonazepam + Propranolol tablets.
DELOTRIL-PRO-LS is an oral prescription tablet from the Blessme division of Dellwich Lifescience. It combines Clonazepam IP 0.25 mg (a high-potency benzodiazepine) with Propranolol Hydrochloride IP 10 mg (a non-selective beta blocker). The abbreviation 'LS' stands for Low Strength, designed to provide calming relief from physical and emotional anxiety symptoms with minimum sedation.
DELOTRIL-PRO-LS works through dual complementary action: Clonazepam modulates central GABA_A receptors to enhance inhibitory chloride influx in the amygdala, producing limbic calmness. Simultaneously, Propranolol blocks peripheral beta-1 and beta-2 adrenergic receptors, directly preventing adrenaline-induced physical symptoms like palpitations, tachycardia, and hand tremors.
DELOTRIL-PRO-LS contains Clonazepam 0.25 mg combined with 10 mg of Propranolol, whereas DELOTRIL-PRO-0.25 contains Clonazepam 0.25 mg paired with 20 mg of Propranolol. The LS formulation is optimal for patients sensitive to beta-blockers, individuals requiring subtle autonomic buffering without blood pressure dips, or patients initiating therapy.
Yes. DELOTRIL-PRO-LS is widely prescribed by psychiatrists for performance anxiety, public speaking panic, and situational stress. The Propranolol component stops somatic tremors, voice quivering, and tachycardia, while low-dose Clonazepam quiets cognitive anticipatory panic without causing drowsiness.
For situational or performance anxiety, clinicians typically advise taking one tablet approximately 30 to 60 minutes prior to the stress-inducing event, strictly in accordance with psychiatric recommendations.
Because Propranolol is a beta-blocker, it naturally moderates heart rate and can slightly lower blood pressure. The 10 mg dose in DELOTRIL-PRO-LS has a gentle cardiovascular profile, but patients with pre-existing hypotension, sick sinus syndrome, or severe bradycardia must avoid its use.
No. Non-selective beta blockers like Propranolol can block bronchial beta-2 receptors, potentially triggering bronchospasm. DELOTRIL-PRO-LS is contraindicated in patients with bronchial asthma or severe chronic obstructive pulmonary disease (COPD).
If taken continuously for several weeks, DELOTRIL-PRO-LS must never be stopped abruptly. Gradual dose tapering under psychiatric supervision prevents rebound tachycardia, anxiety spikes, and autonomic withdrawal crises.
No. Alcohol potentiates the central nervous system depressant effects of Clonazepam, causing severe sedation, impaired motor coordination, respiratory depression, and extreme hypotension. Alcohol consumption must be strictly avoided.
DELOTRIL-PRO-LS is packaged in high-grade 10x10 and 20x10 blister strips manufactured with moisture-barrier foils, ensuring extended shelf life and active ingredient potency.
DELOTRIL-PRO-LS contains Clonazepam 0.25 mg + Propranolol 10 mg (ideal for mild somatic anxiety and performance tremors). In contrast, DELOTRIL-PRO-0.5 contains Clonazepam 0.5 mg + Propranolol 20 mg (indicated for moderate-to-severe panic crises and intense cardiovascular hyperarousal).
Pharmaceutical distributors, stockists, and medical representatives can submit an enquiry through our online form below or contact our neuropsychiatry franchise desk at +91 99099 31992 for monopoly district allocation.
Yes. Dellwich Lifescience provides turnkey third-party manufacturing for Clonazepam + Propranolol combinations in various strengths with GMP certification, customized branding, and on-time shipment dispatch.
Dellwich Lifescience LLP is headquartered in Ahmedabad, Gujarat, India — one of the nation's premier pharmaceutical hubs with rapid logistics connections across all Indian states.
Connect directly with Dellwich Lifescience LLP for trade pricing, district monopoly PCD rights, third-party manufacturing, or institutional hospital tender supplies.
Get wholesale pricing, PCD franchise monopoly rights, and technical documentation for Clonazepam + Propranolol Tablets.